Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities.To determine the contribution of NF1 expression to NF1 vasculopathy, the expression of the NF1 gene product, neurofibromin,was examined in blood vessels.Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to express NF1 mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels.The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed. bispecific, cancer therapy, single chain antibodies
Introduction
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder affecting approximately 1 in 3500 individuals. Individuals with NF1 may exhibit neurofibromas, café-aulait spots, axillary and inguinal freckling, Lisch nodules, optic nerve gliomas, skeletal abnormalities, and learning disabilities (Riccardi 1991) . One of the less appreciated but potentially significant complications of NF1 involves the vascular system. Vascular lesions in NF1 most commonly present as hypertension secondary to renal artery stenosis but can also manifest as arterial occlusion resulting in cerebral and visceral infarcts as well as arterial aneurysms resulting in haemorrhage. The incidence of vascular lesions in NF1 is likely underestimated since routine screening is not performed (Riccardi 1992) .
Neurofibromin is expressed in neurones, Schwann cells and oligodendrocytes, adrenal medulla and leucocytes in rodent tissues (Daston et al. 1992 , Boyer et al. 1994 . The frequency of vascular abnormalities in individuals with NF1 suggests that neurofibromin might be expressed in blood vessels. Previous studies on neurofibromin have demonstrated that it is a 250 kDa phosphoprotein that shares sequence and functional similarity with the family of GAP proteins (GTPase activating proteins), which downregulate p21-ras (Ballester et al. 1990 , Martin et al. 1990 , Xu et al. 1990 . Neurofibromin has been shown to associate with cytoplasmic microtubules in fibroblasts and Schwann cells (Gregory et al. 1993, Gutmann & Rutkowski, unpublished results) . In addition, neurofibromin functions as a negative growth regulator either by downregulating p21 ras activity (DeClue et al. 1992 , Basu et al. 1992 or through ras independent mechanisms (Johnson et al. 1994) . In this report, NF1 expression is detected in the endothelial layer of bovine and rodent cerebral and renal arteries as well as aorta. There is additional expression of neurofibromin in the smooth muscle layer of aorta only. NF1 expression in blood vessels suggests that the increased incidence of vascular pathology in individuals with NF1 may be related to reduced neurofibromin expression.
Materials and methods

Tissues
Adult rat tissues were obtained from freshly killed adult animals according to the guidelines established by the
